Devices › Device types
FDA product code MHX · class 2 · Cardiovascular
Monitor, physiological, patient(with arrhythmia detection or alarms): medical device reports filed with FDA
32,636 reports carry this product code, 1992–2026; 30 brands with a page.
- 32,636
- reports with this product code
- 0.1% of all MAUDE reports
- 4,913
- reports, 12 months to August 2026
- 3,264 in the 12 months before
- 82.1%
- classified as malfunction
- 62.3% across all reports
- 5.9%
- classified as death, as reported
- 0.9% across all reports
Product code MHX is FDA's classification for "Monitor, physiological, patient(with arrhythmia detection or alarms)" (cardiovascular panel), a class 2 device. 32,636 medical device reports carry this product code, 0.1% of the MAUDE database, from March 1992 to August 2026.
4,913 reports arrived in the 12 months to August 2026, up 51% from 3,264 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (82.1%), injury (11.2%) and death (5.9%). 30 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Philips Medical Systems | 9,221 | 28.3% |
| Nihon Kohden | 5,603 | 17.2% |
| Philips Medizin Systeme B Blingen | 3,792 | 11.6% |
| Remote Diagnostic Technologies | 2,715 | 8.3% |
| Mindray Ds USA | 2,366 | 7.2% |
| Zoll Manufacturing | 2,260 | 6.9% |
| Spacelabs Healthcare | 1,350 | 4.1% |
| Philips North America | 874 | 2.7% |
| Draeger Medical Systems | 617 | 1.9% |
| Ge Healthcare | 578 | 1.8% |
| Philips Healthcare | 164 | 0.5% |
| Datascope | 139 | 0.4% |
| Welch Allyn | 65 | 0.2% |
| Welch Allyn Protocol | 60 | 0.2% |
| Agilent Technologies | 24 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| No audible alarm | 3,741 | 11.5% |
| Device operates differently than expectedthe device behaved unexpectedly | 3,051 | 9.3% |
| Device alarm system | 2,645 | 8.1% |
| Communication or transmission problemthe device could not communicate or transmit | 1,952 | 6% |
| Patient device interaction problem | 1,943 | 6% |
| Device displays incorrect message | 1,419 | 4.3% |
| No display/image | 1,350 | 4.1% |
| Device inoperablethe device could not be used | 1,174 | 3.6% |
| No audible prompt/feedback | 1,126 | 3.5% |
| Defective alarm | 1,116 | 3.4% |
| Display or visual feedback problem | 1,054 | 3.2% |
| Output problem | 1,029 | 3.2% |
| Application program problem | 888 | 2.7% |
| Nonstandard device | 836 | 2.6% |
| Unable to obtain readings | 745 | 2.3% |
| Unintended application program shut down | 620 | 1.9% |
| Computer operating system problem | 607 | 1.9% |
| Incorrect measurementthe device measured wrongly | 555 | 1.7% |
| Power problem | 519 | 1.6% |
| Wireless communication problema wireless connection problem | 496 | 1.5% |
Questions about monitor, physiological, patient(with arrhythmia detection or alarms) reports
What is product code MHX?
FDA's classification code for "Monitor, physiological, patient(with arrhythmia detection or alarms)", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
32,636 reports through August 2026, 4,913 of them in the latest 12 months.
Which brands appear most often?
Patient Information Center iX (1,940), uCor Heart Failure and Arrhythmia Management System (1,877), Tempus Pro (1,850), Cns-6201a (1,720) and IntelliVue Multi Measurement Server X2 (1,355). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.